Eli Lilly's Elanco division is planning to pay more than $300 million for Monsanto's artificial dairy cow hormone, Posilac. Posilac increases milk production but faces mounting public concerns over its safety.
The genetically engineered protein is injected into dairy cows to prevent mammary cell death. Posilac opponents point to studies that show cows given Posilac have higher rates of udder infections and increased production of a substance, called bovine insulin-like growth factor 1, that has been linked to cancer.
Monsanto putt the product up for sale recently, after marketing it for 14 years.
Original Article: Eli Lilly Pays Monsanto $300 Million for Controversial Dairy Hormone
Notice: The preceding article was not written by a member of the Anti-Aging Revolution. This article is provided for informational and reference purposes only. The Anti-Aging Revolution cannot guarantee the stability of third-party outside links.
